These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 27067440)

  • 41. Intussusception Rate Among Under-Five-Children Before Introduction of Rotavirus Vaccine in North India.
    Gupta M; Kanojia R; Singha R; Tripathy JP; Mahajan K; Saxena A; Bansal A; Muralidharan J; Kumar R
    J Trop Pediatr; 2018 Aug; 64(4):326-335. PubMed ID: 29040742
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risk of intussusception after monovalent rotavirus vaccination.
    Weintraub ES; Baggs J; Duffy J; Vellozzi C; Belongia EA; Irving S; Klein NP; Glanz JM; Jacobsen SJ; Naleway A; Jackson LA; DeStefano F
    N Engl J Med; 2014 Feb; 370(6):513-9. PubMed ID: 24422678
    [TBL] [Abstract][Full Text] [Related]  

  • 43. European Society for Paediatric Infectious Diseases consensus recommendations for rotavirus vaccination in Europe: update 2014.
    Vesikari T; Van Damme P; Giaquinto C; Dagan R; Guarino A; Szajewska H; Usonis V
    Pediatr Infect Dis J; 2015 Jun; 34(6):635-43. PubMed ID: 25860532
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association Between Rotavirus Vaccination and Risk of Intussusception Among Neonates and Infants: A Systematic Review and Meta-analysis.
    Lu HL; Ding Y; Goyal H; Xu HG
    JAMA Netw Open; 2019 Oct; 2(10):e1912458. PubMed ID: 31584679
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Uptake and timeliness of rotavirus vaccination in Norway: The first year post-introduction.
    Valcarcel Salamanca B; Hagerup-Jenssen ME; Flem E
    Vaccine; 2016 Sep; 34(39):4684-4689. PubMed ID: 27522178
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intussusception after rotavirus vaccines reported to US VAERS, 2006-2012.
    Haber P; Patel M; Pan Y; Baggs J; Haber M; Museru O; Yue X; Lewis P; Destefano F; Parashar UD
    Pediatrics; 2013 Jun; 131(6):1042-9. PubMed ID: 23669521
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Trends in intussusception hospitalizations among US infants, 1993-2004: implications for monitoring the safety of the new rotavirus vaccination program.
    Tate JE; Simonsen L; Viboud C; Steiner C; Patel MM; Curns AT; Parashar UD
    Pediatrics; 2008 May; 121(5):e1125-32. PubMed ID: 18450856
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk of intussusception after monovalent rotavirus vaccine (Rotavac) in Indian infants: A self-controlled case series analysis.
    INCLEN Intussusception Surveillance Network Study Group
    Vaccine; 2021 Jan; 39(1):78-84. PubMed ID: 32972735
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Does Rotavirus Vaccination Affect Longer-Term Intussusception Risk in US Infants?
    Burke RM; Tate JE; Dahl RM; Aliabadi N; Parashar UD
    J Pediatric Infect Dis Soc; 2020 Apr; 9(2):257-260. PubMed ID: 31197368
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Retrospective hospital based surveillance of intussusception in children in a sentinel paediatric hospital: benefits and pitfalls for use in post-marketing surveillance of rotavirus vaccines.
    Lloyd-Johnsen C; Justice F; Donath S; Bines JE
    Vaccine; 2012 Apr; 30 Suppl 1():A190-5. PubMed ID: 22520131
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intussusception Rates Before and After the Introduction of Rotavirus Vaccine.
    Tate JE; Yen C; Steiner CA; Cortese MM; Parashar UD
    Pediatrics; 2016 Sep; 138(3):. PubMed ID: 27558938
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of Intussusception After Oral Monovalent Rotavirus Vaccination in South Africa.
    Groome MJ; Tate JE; Arnold M; Chitnis M; Cox S; de Vos C; Kirsten M; le Grange SM; Loveland J; Machaea S; Maharaj A; Andrews N; Madhi SA; Parashar UD
    Clin Infect Dis; 2020 Apr; 70(8):1606-1612. PubMed ID: 31125061
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rotavirus vaccines and intussusception risk.
    Bines JE
    Curr Opin Gastroenterol; 2005 Jan; 21(1):20-5. PubMed ID: 15687880
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The risk of intussusception following monovalent rotavirus vaccination in England: A self-controlled case-series evaluation.
    Stowe J; Andrews N; Ladhani S; Miller E
    Vaccine; 2016 Jul; 34(32):3684-9. PubMed ID: 27286641
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intussusception following rotavirus vaccination: an updated review of the available evidence.
    Rha B; Tate JE; Weintraub E; Haber P; Yen C; Patel M; Cortese MM; DeStefano F; Parashar UD
    Expert Rev Vaccines; 2014 Nov; 13(11):1339-48. PubMed ID: 25066368
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Approaches to monitoring intussusception following rotavirus vaccination.
    Tate JE; Parashar UD
    Expert Opin Drug Saf; 2019 Jan; 18(1):21-27. PubMed ID: 30570424
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Update on the global epidemiology of intussusception: a systematic review of incidence rates, age distributions and case-fatality ratios among children aged <5 years, before the introduction of rotavirus vaccination.
    Clark AD; Hasso-Agopsowicz M; Kraus MW; Stockdale LK; Sanderson CFB; Parashar UD; Tate JE
    Int J Epidemiol; 2019 Aug; 48(4):1316-1326. PubMed ID: 30879038
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sustained low hospitalization rates after four years of rotavirus mass vaccination in Austria.
    Paulke-Korinek M; Kollaritsch H; Aberle SW; Zwazl I; Schmidle-Loss B; Vécsei A; Kundi M
    Vaccine; 2013 May; 31(24):2686-91. PubMed ID: 23597718
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of Intussusception after Monovalent Rotavirus Vaccination in Africa.
    Tate JE; Mwenda JM; Armah G; Jani B; Omore R; Ademe A; Mujuru H; Mpabalwani E; Ngwira B; Cortese MM; Mihigo R; Glover-Addy H; Mbaga M; Osawa F; Tadesse A; Mbuwayesango B; Simwaka J; Cunliffe N; Lopman BA; Weldegebriel G; Ansong D; Msuya D; Ogwel B; Karengera T; Manangazira P; Bvulani B; Yen C; Zawaira FR; Narh CT; Mboma L; Saula P; Teshager F; Getachew H; Moeti RM; Eweronu-Laryea C; Parashar UD;
    N Engl J Med; 2018 Apr; 378(16):1521-1528. PubMed ID: 29669224
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Using Discretely Integrated Condition Event Simulation To Construct Quantitative Benefit-Risk Models: The Example of Rotavirus Vaccination in France.
    Arlegui H; Nachbaur G; Praet N; Bégaud B; Caro JJ
    Clin Ther; 2020 Oct; 42(10):1983-1991.e2. PubMed ID: 32988633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.